AngioDynamics launches long-term study of NanoKnife for prostate cancer [Yahoo! Finance]
ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE [Yahoo! Finance]
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
AngioDynamics' NanoKnife System gains CPT codes for prostate and liver treatments [Yahoo! Finance]
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver